NCT03390504 2026-02-02THORJanssen Research & Development, LLCPhase 3 Active not recruiting629 enrolled 32 charts 1 FDA
NCT03474107 2026-01-09A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)Astellas Pharma IncPhase 3 Completed608 enrolled 22 charts 1 FDA
NCT00545766 2021-12-16Vinflunine in Hormone Refractory Prostate Cancer (HRPC)SCRI Development Innovations, LLCPhase 2 Completed41 enrolled 11 charts
NCT02302807 2019-08-01A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211]Hoffmann-La RochePhase 3 Completed931 enrolled 21 charts